Cocrystal Pharma Inc (OTCBB:COCP), which happens to be a clinical stage biotechnology company that majorly focuses on antiviral therapeutics has today gone ahead to make the much awaited announcement. It was a moment of great relief to most of the concerned parties after the announcement was made that indeed James J. Martin had been appointed to become the new Chief Financial Officer and expectations are on the rise with most of the people hoping that he is going to help much towards helping steer the company to the top in terms of achieving tremendous business success.
Earlier on, the top executive had been serving Cocrystal in the position of the Interim Chief Financial Officer. What a lot of people are counting on is the fact that he is moving in with about 25 years of experience in financial leadership positions and executive management for private and public companies.
Cocrystal Pharma’s interim Chief Executive Officer, Dr. Gary Wilcox while driving a point home in one of the recent board meetings said, “Jim is an accomplished executive with significant financial and operational expertise, and I’m thrilled to welcome him to Cocrystal. His expertise will help us drive our financial objectives and continue our commitment to long-term shareholder value.”
The top-notch company according to what was lately said by one of the officials that has worked working with it for quite a long period of time, has come heads on with numerous challenges. However, it has been able to pick itself up time and again and move towards the greatest heights of business success.
However, by Mr. Martin stepping in and carrying out his assigned roles the company is expected to rise even higher in term of hitting its targets and rising to the pinnacle in terms of hitting the highest milestones in terms of business success.
When it came to Mr. Martin’s turn to give his speech, he started off by thanking the company’s board of directors for settling for him to serve in the given capacity. He promised to join hands with the rest of the company top officials to help steer the company towards great success as well as sharpen its competitive edge.
For consideration of being featured on WallstreetPR, contact: Editor@Wallstreetpr.com
